Category: Stents
Global Stents
-
Global Primary Sclerosing Cholangitis Market - 2024-2031
... is driven by factors such as the increasing prevalence of primary sclerosing cholangitis, research activities, technological advancements, research funding, and collaboration among key players. Inflammatory bowel disease, which is characterized by intestinal inflammation that results ... Read More
-
Global Interventional Cardiology Market - 2024-2031
... a medical specialty that uses a thin, flexible tube known as a catheter to repair damaged or weakened vessels, narrowed arteries, or other structural issues with the heart. Cardiac interventions frequently eliminate the need for ... Read More
-
Gastrointestinal Stents Market Report by Product Type (Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents, Esophageal Stents), Technology Type (Anti-Migratory Stents, Drug-Eluting Stents, Radioactive Stents, Anti-Reflux Stents, Shape-Modified Stents, and Others), Material (Plastic Stents, Self-Expanding Metal Stents, Covered Self-Expandable Metallic Stents, Biodegradable or Drug Eluting Stents), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres, and Others), and Region 2025-2033
... A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube ... Read More
-
Cardiovascular Implants Market Report by Product Type (Coronary Stent, ICD, Heart Valve, Implanted Cardiac Pacemaker, CRT Device, Peripheral Stent), Material (Metals and Alloys, Polymers, Biological Materials), Procedure Type (Angioplasty, Open Heart Surgery), Indication (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Congestive Heart Failure, and Others), and Region 2025-2033
... The rising prevalence of cardiovascular diseases, the expanding geriatric population, and significant advancements in the healthcare sector, represent some of the key factors driving the market. Cardiovascular implants are specialized medical tools used to treat ... Read More
-
Bioresorbable Stents
... CAGR of 12.1% over the analysis period 2024-2030. Polymer-based Bioresorbable Stents, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$905.2 Million by the end of the ... Read More
-
Coronary Guidewires
... CAGR of 4.4% over the analysis period 2024-2030. Nitinol-Based Coronary Guidewires, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$550.2 Million by the end of the ... Read More
-
Venous Stents
... CAGR of 8.4% over the analysis period 2024-2030. Iliac Vein Stent Technology, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Aortic Stent Grafts
... at a CAGR of 4.9% over the analysis period 2024-2030. Abdominal Aortic Stent Grafts, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$2.9 Billion by the ... Read More
-
Benign Prostatic Hyperplasia Devices
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. TURP Procedure, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$389.8 Million by the ... Read More
-
Arterial Stents
... CAGR of 8.3% over the analysis period 2024-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$12.8 Billion by the end of the analysis ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Coronary Stents
... CAGR of 5.4% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.6 Billion by the end of the ... Read More
-
Vascular Stents
... CAGR of 4.3% over the analysis period 2024-2030. Balloon-Expandable Stents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.2 Billion by the end of the analysis ... Read More
-
Drug Device Combination Products
... 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Transdermal Patches, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$53.4 Billion by the ... Read More
-
Biodegradable Stents
... CAGR of 35.0% over the analysis period 2024-2030. Coronary Artery Stents, one of the segments analyzed in the report, is expected to record a 34.9% CAGR and reach US$15.6 Billion by the end of the ... Read More
-
Guidewires
... 4.2% over the analysis period 2024-2030. Stainless Steel Guidewires, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$303.5 Million by the end of the analysis period. ... Read More
-
Gastrointestinal Stents
... CAGR of 5.9% over the analysis period 2024-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of the analysis ... Read More
-
Neurovascular Stents
... CAGR of 9.7% over the analysis period 2024-2030. Carotid Artery Stents, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Airway/Lung Stents
... CAGR of 5.4% over the analysis period 2024-2030. Tracheal Stents, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$96.6 Million by the end of the analysis ... Read More
-
Intracranial Stents
... CAGR of 12.9% over the analysis period 2024-2030. Self-Expanding Stents, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$594.0 Million by the end of the analysis ... Read More
-
Pediatric Interventional Cardiology Devices
... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More
-
Coatings for Medical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Anti-Microbial Coatings, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$7.7 Billion by the ... Read More
-
Pressure Guidewires
... CAGR of 8.6% over the analysis period 2024-2030. Flat Tipped Pressure Guidewires, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Percutaneous Coronary Intervention (PCI) Devices
... Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.4 Billion ... Read More
-
Vascular Grafts
... CAGR of 7.2% over the analysis period 2024-2030. Endovascular Aneurysm Repair (EVAR) Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.6 Billion by the end ... Read More
Research Assistance
